Moderna (MRNA) is up more than +3% after reporting Q3 Covid-19 vaccine ... MercadoLibre (MELI) is down more than -16% to lead losers in the Nasdaq 100 after reporting Q3 adjusted Ebitda of $714.0 ...
Moderna (MRNA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Tyler Van Buren ...
Shares of Moderna Inc. MRNA slid 2.95% to $50.28 Thursday, on what proved to be an all-around mixed trading session for the ...
Officinae Bio’s breakthroughs in AI-enabled methodologies for nucleic manufacturing to enhance Maravai’s mRNA manufacturing ...
Hosted on MSN9h
Trump's Potential 'Health Czar' Robert F. Kennedy Jr. Rattles Vaccine Stocks: 'Shoot First Reaction'Market Reaction: Big Pharma's vaccine names dipped on Wednesday with Moderna, Inc. (NASDAQ:MRNA) ending the day down 2.78%, ...
Welcome to the Moderna third quarter 2024 conference call. [Operator instructions] Please be advised today's conference is ...
Q3 results confirms that the U.S. vaccine market for respiratory syncytial virus (RSV), led by Pfizer (PFE) and GSK (GSK), is ...
Zacks.com on MSN14h
Initial Claims Increased Slightly More Than ExpectedBoth the Dow and the Nasdaq are +80 points at this hour, with the S&P 500 up +15 points.New Jobless Claims Stay Tame; Longer-Term Claims HigherThis being Thursday morning, we nearly always look for ...
On Thursday, Moderna Inc (NASDAQ:MRNA) stock is trading higher after the company reported better-than-expected third-quarter ...
Moderna (NASDAQ:MRNA) has reported a surprise net income in the third quarter and announced changes at its leadership team, ...
MT Newswires on MSN17h
Stock Futures Rise Amid Trump Victory as Traders Focus on Fed Decision; Asia, Europe RiseUS equity markets were pointing higher before the opening bell Thursday, poised to build on the record highs hit a day earlier as investors processed Donald Trump's victory in the US presidential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback